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Sir,
High-risk human papilloma viruses (HPVs) have been consis-
tently identified in 13–86% of breast tumours in the 10 studies
published since 1999 (Lawson et al, 2006). High-risk HPVs of the
same type have been identified in both cervical and breast cancer
that had occurred in the same women (Hennig et al, 1999;
Widschwendter et al, 2004). This observation has lead to the
hypothesis that HPVs may be transmitted to the breast during
sexual activities (Kan et al, 2005). If this hypothesis is correct, it
is likely that HPV-positive breast cancers would occur in women
younger than those with HPV-negative breast cancer. This is
because HPV genital infections are much more common in young
women who have had multiple sexual partners (IARC, 1995).
There are only two studies in which the age of women with
HPV-positive and -negative breast cancer has been published.
There were no differences in the average of age of women with
either HPV-positive and -negative breast cancer in a study of
Brazilian women (Damin et al, 2004). This is in contrast to a recent
study of Greek women in which those with HPV-positive breast
cancer were of average age 38 years as compared to average age 53
years for women with HPV-negative breast cancer (P-values for
difference¼0.001) (Kroupis et al, 2006).
We have reviewed the ages of Australian women with HPV-
positive and -negative breast cancer in our study published in this
Journal (Kan et al, 2005). These data are shown in Table 1. The
average age of women with HPV-positive breast cancer was 55.6
years as compared to 63.8 years for women with HPV-negative
breast cancer (P-values for difference¼0.049). These data are
compatible with the hypothesis that HPV-positive breast cancers
occur in younger women than those with HPV-negative breast
cancers, and that high-risk HPVs may have been transmitted by
sexual activity with HPV-positive sexual partners.
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Table 1 Age of Australian women with HPV-positive and -negative
breast cancer
HPV positive HPV negative
Number of women 24 26
Average age (years) 55.6 63.8
HPV¼human papilloma virus. P-value for difference in average ages¼0.049, which is
significant at the 95% level.
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